Skip to main content
. 2019 Aug 23;13:899. doi: 10.3389/fnins.2019.00899

TABLE 1.

Demographic and clinical characteristics of neonates divided according to the NICI score categories.

Control-group IP-group P

NICI score 0 I II III
N° neonates 13 7 20 6
Gestational age (week) Median (range) 31.2 (27.1–32.8) 28.2 (27.3–29.1) 27.1 (26.3–30.2) 27.9 (25.3–31.7) 0.085
Postmenstrual age at MRI (week) Median (range) 40.1 (39.1–41.2) 40.1 (39.3–40.3) 40.8 (38.9–41.3) 40.3 (39.4–41.9) 0.832
Birth weight (gr) Median (range) 1189.25 (863.81–1514.21) 1090.88 (844.32–1427.32) 1060.18 (713.41–1523.78) 1190.21 (756.54–1497.59) 0.743
Gender N°neonates (%) 0.833
Male 5 (38%) 4 (57%) 8 (40%) 3 (50%)
Female 8 (62%) 3 (43%) 12 (60%) 3 (50%)
APGAR 1’ Median (range) 8.81 (5–10) 6.97 (5–9) 6.43 (5–8) 6.58 (5–7) 0.011
APGAR 5’ Median (range) 9.15 (7–10) 8.91 (7–10) 8.21 (6–9) 7.22 (6–8) 0.003
Days of mechanical ventilation Median (range) 0 (0) 2 (0–4) 6 (2–15) 9 (3–21) <0.001
Morphine dose Median (range); N° neonates 0 (0); 0 0.15 (0.13–0.19); 4 1.8 (0.51–3.9); 16 2.93 (0.6–10.5); 6 <0.001
Midazolam dose Median (range); N°neonates 0 (0); 0 1.2 (1–3.5); 4 2.3 (1.5–6.7); 7 6.5 (3.9–11.7); 5 <0.001
Dexamethasone dose Median (range); N°neonates 0 (0); 0 0.94 (0.8–1.2); 3 0.88 (0.7–1.2); 7 1.2 (0.75–2.1); 4 <0.001
Total skin breaks Median (range) 1 (1–3) 9 (5–12) 13 (7–19) 28 (9–41) <0.001
Endotracheal intubation N°neonates (%) 0 (0%) 0 (0%) 20 (100%) 6 (100%) <0.001
Surgery N°neonates (%) 0 (0%) 0 (0%) 0 (0%) 6 (100%) <0.001

P indicates significance level of statistic comparisons. Continuous and categorical measures were compared using the Kruskall-Wallis and X2 tests, respectively. Control group, neonates not requiring invasive procedures; IP group, neonates requiring invasive procedures. NICI score, neonatal intensive care invasiveness score. Cumulative dose in milligrams adjusted for daily body weight (Kg).